¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"RE"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 13 ÆäÀÌÁö: 13
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
  • JrId: 6875
    JournalTitle: The Regan report on nursing law.
    MedAbbr: Regan Rep Nurs Law
    ISSN: 0034-3196
    ESSN:
    IsoAbbr:
    NlmId: 352140
  • JrId: 6879
    JournalTitle: Reanimation et organes artificiels. Wiederbelebung und kunstliche Organe. Reanimation and artificial organs.
    MedAbbr: Reanim Organes Artif
    ISSN: 0079-9904
    ESSN:
    IsoAbbr:
    NlmId: 401267
  • JrId: 6880
    JournalTitle: Respiratory care.
    MedAbbr: Respir Care
    ISSN: 0020-1324
    ESSN:
    IsoAbbr:
    NlmId: 7510357
  • JrId: 6881
    JournalTitle: The Reader's digest.
    MedAbbr: Read Dig
    ISSN: 0034-0375
    ESSN:
    IsoAbbr:
    NlmId: 9877792
  • JrId: 6882
    JournalTitle: Record of chemical progress.
    MedAbbr: Rec Chem Prog
    ISSN: 0034-1584
    ESSN:
    IsoAbbr:
    NlmId: 7514094
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Q60.2
    Renal agenesis, unspecified
    »ó¼¼ºÒ¸íÀÇ ÄáÆÏ(½ÅÀå) ¹«¹ß»ýÁõ
  • N15.1
    Renal and perinephric abscess
    ÄáÆÏ(½ÅÀå) ¹× ÄáÆÏ(½ÅÀå)ÁÖÀ§ °í¸§Áý(³ó¾ç)
  • Q61.4
    Renal dysplasia
    ÄáÆÏ(½ÅÀå) Çü¼ºÀÌ»ó
  • O08.4
    Renal failure following abortion and ectopic and molar pregnancy
    À¯»ê, ÀÚ±Ã¿Ü ÀӽŠ¹× ±âÅ Àӽſ¡ µû¸¥ ÄáÆÏ(½ÅÀå)±â´É»ó½Ç
  • Q60.4
    Renal hypoplasia, bilateral
    ¾çÂʼº ÄáÆÏ(½ÅÀå) Çü¼ºÀúÇÏÁõ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • recruiting response
    µ¿¿ø¹ÝÀÀ
  • recruitment
    1. ¹Ý»çÁ¡Áõ 2. À½·®Áö°¢Áõ°¡ 3. Ȱ¼º¿îµ¿´ÜÀ§Áõ°¡ 4. µ¿¿ø, º¸Ãæ
  • recruitment factor
    µ¿¿øÀÎÀÚ
  • recruitment interval
    Á¡Áõ°£°Ý
  • recruitment pattern
    Á¡Áõ¾ç»ó
  • recruitment phenomenon
    Á¡ÁõÇö»ó, º¸ÃæÇö»ó, ´©°¡Çö»ó
  • recrystallization
    Àç°áÁ¤È­
  • rectal
    Á÷Àå-, °ðâÀÚ-
  • rectal aganglionosis
    Á÷À幫½Å°æÀýÁõ, °ðâÀڽŰæÀý¾øÀ½Áõ
  • rectal ampulla
    Á÷À寨´ë, °ðâÀÚÆØ´ë
  • rectal anesthesia
    Á÷À帶Ãë, °ðâÀÚ¸¶Ãë
  • rectal application
    Á÷Àå³»Åõ¿©, °ðâÀÚ³»Åõ¿©
  • rectal artery
    °ðâÀÚµ¿¸Æ, Á÷À嵿¸Æ
  • rectal atresia
    Á÷ÀåÆó¼â(Áõ), °ðâÀÚÆó¼â(Áõ)
  • rectal bleeding
    Á÷ÀåÃâÇ÷, °ðâÀÚÃâÇ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • regressive behavior
    ÅðÇàÇൿ
  • regular astigmatism
    ±ÔÄ¢³­½Ã
  • regular insulin
    ¼ÓÈ¿Àν¶¸°, ºü¸¥ÀÛ¿ëÀν¶¸°
  • regulation
    ±ÔÁ¤, Á¶Àý
  • regulator
    Á¶ÀýÀÎÀÚ, Á¶Àý±â
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ
  • regulatory enzyme
    Á¶ÀýÈ¿¼Ò
  • regurgitant murmur
    ¿ª·ùÀâÀ½
  • regurgitation
    ¿ª·ù
  • rehabilitation
    ÀçȰ
  • rehabilitation center
    ÀçȰ¿ø, ÀçȰ¼¾ÅÍ
  • rehabilitation medicine
    ÀçȰÀÇÇÐ
  • rehabilitation nursing
    ÀçȰ°£È£
  • rehalation
    ÀçÈíÀÔ
  • rehearsal
    ¿¹Ç࿬½À
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • recommended dietary allowance
    ¿µ¾ç±ÇÀå·®, À½½Ä¹°±ÇÀå·®
  • recomposition
    ÀçÁ¶¼º, À籸¼º
  • recompression
    Àç°¡¾Ð
  • recon
    ÀçÁ¶ÇÕ´ÜÀ§À¯ÀüÀÚ
  • reconstituted milk
    °¡°ø¿ìÀ¯
  • reconstruction
    Àç°Ç(¼ú), À籸¼º
  • reconstruction algorithm
    À籸¼º¿¬»ê
  • reconstructive operation
    Àç°Ç¼ö¼ú
  • reconstructive rhinoplasty
    ÄÚÀç°Ç¼ºÇü¼ú
  • reconstructive surgery
    Àç°Ç¼ö¼ú, Àç°Ç¿Ü°ú
  • record
    ±â·Ï
  • record keeping
    ±â·Ïº¸°ü
  • record linkage
    ÀڷῬ°è
  • record management
    ±â·Ï°ü¸®
  • recorder
    ±â·Ï±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • recipiomotor
    ¿îµ¿Ãæ°Ý¼ö¿ëÀÇ.
  • reciprocal anchorage
    »ó¹Ý°íÁ¤(ßÓÚãͳïÒ), ±³Á¤(Îìïá).
  • reciprocal articulation
    »óÈ£ °üÀý(ßÓû»Î¼ï½), »ó°ü °üÀý(ßÓμμï½).
  • reciprocal beat
    »ó¹Ý¸Æ¹Ú.
  • reciprocal conduction
    »ó¹ÝÀüµµ.
  • reciprocal crossing
    »ó¹Ý±³¹è(ßÓÚãÎßÛÕ), ¿ª±³Àâ(æ½ÎßíÚ).
  • reciprocal difference
    ¿ªÂ÷ºÐ(æ½ó¬ÝÂ).
  • reciprocal hybrid
    »ó¹ÝÀâÁ¾(ßÓÚãíÚðú).
  • reciprocal inhibition
    »ó¹Ý¾ïÁ¦(ßÓÚãåäð¤).
  • reciprocal inhibition
    »óÈ£¾ïÁ¦
  • reciprocal inhibition psychotherapy
    »óÈ£Á¦ÁöÁ¤½ÅÄ¡·á.
  • reciprocal innervation
    »ó¹Ý½Å°æÁö¹è(ßÓÚããêÌèò¨ÛÕ).
  • reciprocal innervation
    »ó¹ÝÀû½Å°æÁö¹è
  • reciprocal proportion
    ¹Ýºñ·Ê(ËÑËÓËç).
  • reciprocal retention
    »ó¹ÝÁ¤Ã¼(ßÓÚãïÎôò).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • receptor site
    ¼ö¿ëüºÎÀ§.
  • receptor stimulants
    ¼ö¿ëüÀÚ±ØÁ¦.
  • receptor supersensitivity
    ¼ö¿ëü Ãʰ¨¼ö¼º(áôéÄô÷ õ±Êïáôàõ)
  • receptor, T cell
    T¼¼Æ÷(Ç׿ø)¼ö¿ëü
  • receptor-ligand interaction
    ¼ö¿ëü-¹èÀ§ÀÚ »óÈ£ÀÛ¿ë
  • receptors
  • recess of infundibulum ³ª recessus infundibuli
    ±ò´ë±â¿À¸ñ, ´©µÎÇÔ¿ä( שÔà ùèèê).
  • recess of tympanic cavity
    °í½ÇÇÔ¿ä
  • recess of tympanic cavity
    °í½ÇÇÔ¿ä(ÍÕãøùèèê)
  • recess ³ª recessus
    ÇÔ¿ä(ùèèê), µ¿.
  • recess-resect
    ÈÄÀü-ÀýÁ¦¼ú
  • recesses of tympanic membrane
    °í¸·¿À¸ñ
  • recession
    ÅðÃà(÷Üõê).
  • recession
    ÈÄÀü, ÈÄÅð
  • recession of gum
    Ä¡ÀºÅðÃà(öÍó»÷Üõê).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • relaxin
    ¸±·¢½Å
  • relaxing enzyme
    ÀÌ¿Ï È¿¼Ò(ì¬èÐý£áÈ)
  • relaxing factor
    ÀÌ¿Ï ÀÎÀÚ(ì¬èÐì×í­)
  • relaxing protein
    ÀÌ¿Ï ´Ü¹éÁú(ì¬èÐÓ±ÛÜòõ)
  • release factor
    À¯¸® ÀÎÀÚ(ë´×îì×í­)
  • releasing hormone
    À¯¸®(ë´×î) È£¸£¸ó
  • reliability
    ½Å·Úµµ(ãáÖóÓø)
  • relic model
    ÀÜÁ¸(íÑðí) ¸ðµ¨
  • REM
    (å²) Roentgen equivalent man
  • remission
    ¿ÏÈ­(èÐûú)
  • remodeling
    °³ÀÛ(ËÇíÂ)
  • renal clearance
    ½ÅûÁ¤(ãìôèïä)
  • renal compensation
    ½Åº¸»ó(ãìÜÍßÁ)
  • renal glucosuria
    ½Å(ãì)±Û·çÄÚ½º´¢(Òã)
  • renal hypertension
    ½Å°íÇ÷¾Ð(ãìÍÔúìäâ)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • repetition
    ¹Ýº¹
  • repetition time [=TR]
    ¹Ýº¹½Ã°£
  • repetitive pulse method
    ¹Ýº¹ÆÞ½º¹ý
  • rephase
    ˍˤȗ
  • rephasing
    ÀçÀ§»óÈ­
  • rephasing even echo
    ÀçÀ§»ó¦¼ö¿¡ÄÚ
  • rephasing gradient motion
    ÀçÀ§»ó°æ»ç¿îµ¿
  • replacement
    º¹À§, ġȯ
  • replacement atelectasis
    ´ëÄ¡¼º¹«±âÆó
  • replacement therapy
    º¸»ó¿ä¹ý, ´ëÄ¡¿ä¹ý
  • replenisher
    º¸Ãæ¹°, Áõ·®¹°
  • replenisher solution
    Áõ¾×
  • replication
    º¹Á¦
  • report
    º¸°í
  • reproducibility
    ÀçÇö¼º(µµ)
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • reference laboratory
    Âü°í ½ÇÇè
  • reference phantom
    ±âÁØ ¸ðÇü
  • reference plate
    ±âÁØ ÆÇ
  • reference test
    ±âÁØ °Ë»ç¹ý
  • referral
    ¹®ÀÇ, ÀÇ·Ú
  • referral zone
    ÀüÀÌ Áö¿ª
    µ¿ÀǾî=reference zone. ÀüÀÌ
  • referred headache
    ¿¬°ü µÎÅë
  • referred sensation
    ¿¬°ü °¨°¢
  • referred tension headache
    ¿¬°ü¼º ±äÀ强 µÎÅë
  • referred visceral pain
    ³»Àå ¿¬°üÅë
  • refinement
    Á¤Á¦
    À̹°ÁúÀ» Á¦°ÅÇÏ´Â °úÁ¤.
  • reflect
    ¹Ý¿µÇÏ´Ù
  • reflectance coefficient
    ¹Ý»ç °è¼ö
  • reflected image
    ¹Ý»ç ¿µ»ó
  • reflected radiation
    ¹Ý»ç ¹æ»ç¼±, ¹Ý»ç º¹»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
receptors, dopamine d2 A class of dopamine receptors identified by their binding profiles for synthetic ligands, their molecular biology, and, perhaps, their mode of action.
(12 Dec 1998)
receptors, drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behaviour of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified.
(12 Dec 1998)
receptors, eicosanoid Cell surface proteins that bind eicosanoids with high affinity and trigger intracellular changes influencing the behaviour of cells. Among the eicosanoid receptors are receptors for the prostaglandins, thromboxanes, and leukotrienes.
(12 Dec 1998)
receptors, endothelin Cell surface proteins that bind endothelin with high affinity and trigger intracellular changes which influence the behaviour of cells.
(12 Dec 1998)
receptors, epidermal growth factor-urogastrone Glycoproteins of about 170 kD that have protein kinase activity and span the plasma membranes of growing cells, including tumours. They are activated by the binding of epidermal growth factor-urogastrone which then initiates DNA and protein synthesis. They are not found on mitotically quiescent cells except in the stomach where they control the synthesis and release of digestive enzymes and gastric acid. Transforming growth factor alpha also binds to and activates these receptors.
(12 Dec 1998)
receptors, erythropoietin Cell surface proteins that bind erythropoietin with high affinity and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
receptors, estradiol Cytoplasmic proteins that bind estradiol, migrate to the nucleus, and regulate DNA transcription.
(12 Dec 1998)
receptors, fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognise and combine with the fc (crystallizable) portion of immunoglobulin molecules.
(12 Dec 1998)
receptors, fibroblast growth factor Specific molecular sites or structures on cell membranes that react with fibroblast growth factors (both the basic and acidic forms), their analogs, or their antagonists to elicit or to inhibit the specific response of the cell to these factors. These receptors frequently possess tyrosine kinase activity.
(12 Dec 1998)
receptors, fibronectin Specific sites or molecular structures on or in cells with which fibronectins react or to which they bind. Studies have shown that these receptors function in certain types of adhesive contact as well as playing a major role in matrix assembly. These are the traditional fibronectin receptors, also called vla-5 receptors or alpha 5 beta 1 integrins. There are also other integrins that bind fibronectin, including alpha v beta 1.
(12 Dec 1998)
receptors, fsh Cell surface proteins that bind follicle-stimulating hormone (follitropin, fsh) with high affinity and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
receptors, gaba Cell-surface proteins that bind gaba with high affinity and trigger changes that influence the behaviour of cells. Gaba-a receptors control chloride channels formed by the receptor complex itself. They are blocked by bicuculline and usually have modulatory sites sensitive to benzodiazepines and barbiturates. Gaba-b receptors act through g-proteins on several effector systems, are insensitive to bicuculline, and have a high affinity for l-baclofen.
(12 Dec 1998)
receptors, gaba-a Cell surface proteins which bind gaba and control an integral membrane chloride channel. Gaba-a receptors are the most prevalent inhibitory neurotransmitter receptors in the brain. Several isoforms have been cloned, and they belong to a superfamily which includes nicotinic receptors, glycine receptors, and 5ht-3 receptors. Most gaba-a receptors have separate modulatory sites sensitive to benzodiazepines and to barbiturates.
(12 Dec 1998)
receptors, gaba-b Cell surface proteins which bind gaba and influence cells via interactions with g-proteins. Gaba-b receptors are pharmacologically characterised by their insensitivity to the blocker bicuculline and sensitivity to the agonist l-baclofen. They are found both presynaptically and postsynaptically, and act variously by inhibition of adenylate cyclase, activation of phospholipase a2, activation of potassium channels, and inactivation of voltage-activated calcium channels.
(12 Dec 1998)
receptors, gastrointestinal hormone Cell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behaviour of cells. most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 13
  • Receptor, IGF Type 2 - »õâ A receptor that is specific for IGF-II and mannose-6-phosphate. The receptor is a 250-kDa single chain polypeptide which is unrelated in structure to the type 1 IGF receptor (RECEPTOR, IGF TYPE 1) and does not have a tyrosine kinase domain.
    Synonyms : IGF-2 Receptor, Insulin-Like-Growth-Factor II Receptor, Mannose-6-Phosphate Receptor, Receptors, IGF-2, Receptors, Insulin-Like Growth Factor II, IGF 2 Receptor, IGF II Receptor, IGF-2 Receptors, Insulin Like Growth Factor II Receptor, Receptor, IGF II
  • Receptor, Insulin - »õâ A cell surface receptor for INSULIN. It is comprised of a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precusor protein. The receptor contains an intrinsic tyrosine kinase domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the LIVER; MUSCLE; and ADIPOSE TISSUE.
    Synonyms : Insulin Receptor alpha Chain, Insulin Receptor beta Chain, Insulin-Dependent Tyrosine Protein Kinase, Receptors, Insulin, Insulin Receptor Protein Tyrosine Kinase, Insulin Receptors
  • Receptor, Interferon alpha-beta - »õâ A ubiquitously expressed heterodimeric receptor that is specific for both INTERFERON-ALPHA and INTERFERON-BETA. It is composed of two subunits referred to as IFNAR1 and IFNAR2. The IFNAR2 subunit is believed to serve as the ligand-binding chain; however both chains are required for signal transduction. The interferon alpha-beta receptor signals through the action of JANUS KINASES such as the TYK2 KINASE.
    Synonyms : IFN-alphaR, IFN-alphabetaR, IFNAR1 Subunit, Interferon alpha-beta Receptor, IFNAR2 Subunit, Interferon alpha-beta Receptor, IFNAR2.1 Subunit, Interferon alpha-beta Receptor, IFNAR2.2 Subunit, Interferon alpha-beta Receptor, Interferon alpha Receptor
  • Receptor, Macrophage Colony-Stimulating Factor - »õâ A receptor for MACROPHAGE COLONY-STIMULATING FACTOR encoded by the c-fms proto-oncogene (GENES, FMS). It contains an intrinsic protein-tyrosine kinase activity. When activated the receptor undergoes autophosphorylation, phosphorylation of down-stream signaling molecules and rapid down-regulation.
    Synonyms : CD115 Antigen, M-CSF Receptors, Macrophage Colony-Stimulating Factor Receptors, Receptors, CSF-1, Receptors, M-CSF, Receptors, Macrophage Colony-Stimulating Factor, Antigen, CD115, CSF-1 Receptors, Macrophage Colony Stimulating Factor Receptors, Receptor, CSF 1
  • Receptor, Melanocortin, Type 1 - »õâ A melanocortin receptor subtype found primarily in MELANOCYTES. It shows specificity for ALPHA-MSH and ADRENOCORTICOTROPIC HORMONE. Loss of function mutations of the type 1 melanocortin receptor account for the majority of red hair and fair skin recessive traits in human.
    Synonyms : MC1 Receptor, Melanocortin-1 Receptor, Melanocyte Melanocortin Receptor, Receptor, Melanocortin-1, Melanocortin 1 Receptor, Melanocortin Receptor, Melanocyte, Receptor 1, Melanocortin, Receptor, MC1, Receptor, Melanocortin 1, Receptor, Melanocyte Melanocortin
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
·º½ººñŸ¿¬Áúݼ¿ - »õâ
±¤µ¿Á¦¾à
ÀϹÝÀǾàǰ | ¹Ì»ý»ê
·º½º¹Î¿¬Áúݼ¿ - »õâ
´ºÁ¨ÆÊ
ÀϹÝÀǾàǰ | ºñ±Þ¿©
·¹µåÅ©¸°¾× - »õâ
»ïÁøÁ¦¾à
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¸®Ä«¿¤¿¬Áúݼ¿ - »õâ
»ï¼ºÁ¤¹ÐÈ­ÇÐ
Choline Bitartrate, L-cysteine
ÀϹÝÀǾàǰ | ºñ±Þ¿©
·¹°¡Åä´Ð¿¬Áúݼ¿ - »õâ
´ë¿ì¾àǰ°ø¾÷
Aloe extract, Carduus Marianus extract, Chelidonii herba extract, Frangula extract, Lecithin, Taraxaci extract
ÀϹÝÀǾàǰ | ºñ±Þ¿©
·¹Å¥¾î¿¬Áúݼ¿ - »õâ
ÇÁ·¹Áö´Ï¿ì½ºÄ«ºñÄÚ¸®¾Æ
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¸®ÄÚ¸óÇÁ¸®ÇʵåÁÖ4000IU - »õâ
Roche
Recombinant erythropoietin beta
Àü¹®ÀǾàǰ | ¹Ì»ý»ê
·º½º¸¶¸°°ñµå¿¬Áúĸ½¶ - »õâ
µð¿¡½º¾ØÁö
Calcium pantothenate, Carduus Marianus extract, Cyanocobalamin, Nicotinamide, Pyridoxine HCl, Riboflavin, Thiamine HCl
ÀϹÝÀǾàǰ | ºñ±Þ¿©
·¹Å¸Å©´ÒÅ©¸²0.025% - »õâ
°¥´õ¸¶ÄÚ¸®¾Æ
Tretinoin
ÀϹÝÀǾàǰ | ºñ±Þ¿©
·¹Å¸Å©´ÒÅ©¸²0.05% - »õâ
°¥´õ¸¶ÄÚ¸®¾Æ
Tretinoin
Àü¹®ÀǾàǰ | ºñ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
reanimate animate: give new life or energy to; "A hot soup will revive me"; "This will renovate my spirits"; "This treatment repaired my health"
Ãâó: wordnet.princeton.edu/perl/webwn
recreation diversion: an activity that diverts or amuses or stimulates; "scuba diving is provided as a diversion for tourists"; "for recreation he wrote poetry and solved crossword puzzles"; "drug abuse is often regarded as a form of recreation" refreshment: activity that refreshes and recreates; activity that renews your health and spirits by enjoyment and relaxation; "time for rest and refreshment by the pool"; "days of joyous recreation with his friends"
Ãâó: wordnet.princeton.edu/perl/webwn
realgar a rare soft orange mineral consisting of arsenic sulphide; an important ore of arsenic
Ãâó: wordnet.princeton.edu/perl/webwn
reentry the act of entering again
Ãâó: wordnet.princeton.edu/perl/webwn
reflect manifest or bring back; "This action reflects his true beliefs" to throw or bend back or reflect (from a surface); "A mirror in the sun can reflect light into a person's eyes"; "Sound is reflected well in this auditorium" chew over: reflect deeply on a subject; "I mulled over the events of the afternoon"; "philosophers have speculated on the question of God for thousands of years"; "The scientist must stop to observe and start to excogitate" be bright by reflecting or casting light; "Drive carefully--the wet road reflects" give evidence of a certain behavior; "His lack of interest in the project reflects badly on him" give evidence of the quality of; "The mess in his dorm room reflects on the student"
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • reality therapy
    Çö½Ç ¿ä¹ý(ȯÀÚ°¡ óÇÑ Çö½ÇÀ» ÀνÄÄÉÇÏ¿© Çö½Ç¿¡ ÀûÀÀÅä·Ï ÇÏ´Â ½É¸® ¿ä¹ý)
  • realizable
    ½ÇÇöÇÒ ¼ö ÀÖ´Â;½Ç°¨ÇÒ ¼öÀÖ´Â;½Ç°¨ÇÒ ¼ö ÀÖ´Â;Çö±ÝÀ¸·Î ¹Ù²Ü¼ö ÀÖ´Â
  • realization
    ½Ç°¨
  • realization
    »ç½ÇÀ̶ó°í »ý°¢ÇÔ(±ú´ÞÀ½);½ÇÁ¤À» ¾Í;(Èñ¸Á.°èȹ µîÀÇ)½ÇÇö;Çö½ÇÈ­;½Ç¹°°°ÀÌ ±×¸²;Çö±ÝÈ­;(µ·.Àç»êÀÇ)Ãëµæ
  • realize
    ½ÇÇöÇÏ´Ù,±ú´Ý´Ù
  • realize
    ½Ç°¨ÇÏ´Ù;±ú´Ý´Ù;(¸íÈ®È÷)ÀÌÇØÇÏ´Ù;ºÐ¸íÈ÷ ÆÄ¾ÇÇÏ´Ù;½ÇÇöÇÏ´Ù;½ÇÇàÇÏ´Ù;¿©½ÇÈ÷ º¸¿©ÁÖ´Ù;½Ç°¨³ª°Ô ±×¸®´Ù;»ç½ÇÀûÀ¸·Î ÇÏ´Ù;(Àç»ê.ÀÌÀÍÀ»)¾ò´Ù;¹ú´Ù;Çö±ÝÀ¸·Î ¹Ù²Ù´Ù;(¾ó¸¶¿¡)ÆÈ¸®´Ù;µ·À¸·Î ¹Ù²Ù´Ù;µ·ÀÌ µÇ´Ù
  • realized profit
    ½ÇÇö ÀÌÀÍ
  • realliance
    À絿¸Í
  • really
    ½ÇÁ¦·Î
  • really
    Á¤¸»·Î;½ÇÀº;»ç½ÇÀº;ÂüÀ¸·Î;Âø½ÇÈ÷;±×·¡?;¾î¸Ó;¾Æ´Ï?
  • realm
    ¿Õ±¹; ¹üÀ§
  • realm
    ¿Õ±¹(kingdom);±¹Åä;¿µÅä;¹üÀ§;¿µ¿ª;(ºÐ·ùÀÇ)ºÎ¹®;°è;±Ç;´ë(region);(...ÀÇ)¼¼°è
  • realness
    Çö½Ç(½ÇÀç,»ç½Ç)(ÀÓ)
  • Realtor,r-
    (Àü±¹ ºÎµ¿»ê¾÷ÀÚ ¿¬ÇÕȸ¿¡ °¡ÀÔÇÑ)ºÎµ¿»ê ¾÷ÀÚ;°øÀÎ ºÎµ¿»ê Áß°³»ç
  • realty
    ºÎµ¿»ê
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 13
RE written material intended to be read
RE a program designed to teach literacy skills
RE a room set aside for reading
RE someone who teaches students to read
RE adjust anew
RE adjust again after an initial failure
RE the act of adjusting again (to changed circumstances)
RE the act of adjusting something to match a standard
RE the act of admitting someone again
RE admit again or anew
RE admit anew
RE poised for action
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 13
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á